Correlation Between Relmada Therapeutics and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Relmada Therapeutics and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relmada Therapeutics and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relmada Therapeutics and Cue Biopharma, you can compare the effects of market volatilities on Relmada Therapeutics and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relmada Therapeutics with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relmada Therapeutics and Cue Biopharma.
Diversification Opportunities for Relmada Therapeutics and Cue Biopharma
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Relmada and Cue is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Relmada Therapeutics and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Relmada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relmada Therapeutics are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Relmada Therapeutics i.e., Relmada Therapeutics and Cue Biopharma go up and down completely randomly.
Pair Corralation between Relmada Therapeutics and Cue Biopharma
Given the investment horizon of 90 days Relmada Therapeutics is expected to generate 2.17 times more return on investment than Cue Biopharma. However, Relmada Therapeutics is 2.17 times more volatile than Cue Biopharma. It trades about 0.37 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.23 per unit of risk. If you would invest 207.00 in Relmada Therapeutics on August 16, 2025 and sell it today you would earn a total of 188.00 from holding Relmada Therapeutics or generate 90.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Relmada Therapeutics vs. Cue Biopharma
Performance |
| Timeline |
| Relmada Therapeutics |
| Cue Biopharma |
Relmada Therapeutics and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Relmada Therapeutics and Cue Biopharma
The main advantage of trading using opposite Relmada Therapeutics and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relmada Therapeutics position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Relmada Therapeutics vs. Acrivon Therapeutics, Common | Relmada Therapeutics vs. Pmv Pharmaceuticals | Relmada Therapeutics vs. Immunic | Relmada Therapeutics vs. Tscan Therapeutics |
| Cue Biopharma vs. NRX Pharmaceuticals | Cue Biopharma vs. OUTLOOK THERAPEUTICS INC | Cue Biopharma vs. Equillium | Cue Biopharma vs. Coeptis Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |